CV Sciences, Inc. Provides Revenue Guidance for the Second Quarter of 2018
July 25, 2018 at 06:46 pm IST
Share
CV Sciences, Inc. provided revenue guidance for the second quarter of 2018. Second quarter 2018 revenue is expected to be $12.3 million, up 203% compared to the second quarter of 2017, and a 53% sequential increase over first quarter of 2018.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
CV SCIENCES, INC. 
